News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
870,202 Results
Type
Article (87986)
Company Profile (825)
Press Release (781372)
Multimedia
Podcasts (196)
Webinars (28)
Section
Business (233270)
Career Advice (4147)
Deals (39883)
Drug Delivery (151)
Drug Development (91422)
Employer Resources (205)
FDA (18394)
Job Trends (17428)
News (397936)
Policy (39970)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3011)
Academic (2)
Accelerated approval (34)
Adcomms (36)
Allergies (148)
Alliances (56981)
ALS (181)
Alzheimer's disease (1789)
Antibody-drug conjugate (ADC) (346)
Approvals (18574)
Artificial intelligence (626)
Autoimmune disease (162)
Automation (36)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (202)
Biotechnology (490)
Bladder cancer (163)
Brain cancer (65)
Breast cancer (662)
Cancer (5035)
Cardiovascular disease (444)
Career advice (3570)
Career pathing (41)
CAR-T (303)
CDC (59)
Celiac Disease (1)
Cell therapy (825)
Cervical cancer (37)
Clinical research (77024)
Collaboration (1815)
Company closure (5)
Compensation (1155)
Complete response letters (73)
COVID-19 (2992)
CRISPR (99)
C-suite (862)
Cystic fibrosis (154)
Data (6265)
Decentralized trials (2)
Denatured (72)
Depression (151)
Diabetes (532)
Diagnostics (7228)
Digital health (47)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (302)
Drug pricing (224)
Drug shortages (36)
Duchenne muscular dystrophy (239)
Earnings (100143)
Editorial (64)
Employer branding (25)
Employer resources (173)
Events (135071)
Executive appointments (1033)
FDA (21574)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1554)
Gene editing (215)
Generative AI (64)
Gene therapy (671)
GLP-1 (1126)
Government (5441)
Grass and pollen (8)
Guidances (385)
Healthcare (20946)
HIV (60)
Huntington's disease (49)
IgA nephropathy (86)
Immunology and inflammation (292)
Immuno-oncology (59)
Indications (98)
Infectious disease (3279)
Inflammatory bowel disease (206)
Inflation Reduction Act (17)
Influenza (120)
Intellectual property (247)
Interviews (816)
IPO (17954)
IRA (60)
Job creations (5200)
Job search strategy (2866)
JPM (69)
Kidney cancer (17)
Labor market (93)
Layoffs (660)
Leadership (40)
Legal (10160)
Liver cancer (98)
Longevity (16)
Lung cancer (679)
Lymphoma (378)
Machine learning (45)
Management (66)
Manufacturing (852)
MASH (173)
Medical device (15028)
Medtech (15080)
Mergers & acquisitions (22986)
Metabolic disorders (1395)
Multiple sclerosis (161)
NASH (23)
Neurodegenerative disease (355)
Neuropsychiatric disorders (98)
Neuroscience (3109)
Neurotech (1)
NextGen: Class of 2026 (7708)
Non-profit (5112)
Now hiring (66)
Obesity (674)
Opinion (336)
Ovarian cancer (167)
Pain (210)
Pancreatic cancer (231)
Parkinson's disease (300)
Partnered (39)
Patents (509)
Patient recruitment (478)
Peanut (60)
People (66912)
Pharmaceutical (145)
Pharmacy benefit managers (32)
Phase I (23798)
Phase II (33421)
Phase III (25190)
Pipeline (5040)
Policy (336)
Postmarket research (3554)
Preclinical (10693)
Press Release (72)
Prostate cancer (246)
Psychedelics (55)
Radiopharmaceuticals (301)
Rare diseases (903)
Real estate (7440)
Recruiting (80)
Regulatory (29020)
Reports (67)
Research institute (2725)
Resumes & cover letters (651)
Rett syndrome (27)
RNA editing (20)
RSV (83)
Schizophrenia (158)
Series A (257)
Series B (197)
Service/supplier (30)
Sickle cell disease (103)
Special edition (27)
Spinal muscular atrophy (176)
Sponsored (48)
Startups (4333)
State (2)
Stomach cancer (20)
Supply chain (113)
Tariffs (100)
The Weekly (122)
Vaccines (1147)
Venture capital (96)
Weight loss (462)
Women's health (88)
Worklife (21)
Date
Today (71)
Last 7 days (504)
Last 30 days (2476)
Last 365 days (32804)
2026 (2513)
2025 (33230)
2024 (38141)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (89)
Alaska (7)
Arizona (343)
Arkansas (14)
Asia (51561)
Australia (9056)
California (11532)
Canada (3311)
China (1166)
Colorado (488)
Connecticut (499)
Delaware (345)
Europe (118452)
Florida (1688)
Georgia (369)
Hawaii (4)
Idaho (68)
Illinois (964)
India (67)
Indiana (543)
Iowa (24)
Japan (428)
Kansas (133)
Kentucky (43)
Louisiana (29)
Maine (83)
Maryland (1456)
Massachusetts (8487)
Michigan (358)
Minnesota (665)
Mississippi (6)
Missouri (139)
Montana (35)
Nebraska (29)
Nevada (126)
New Hampshire (86)
New Jersey (3106)
New Mexico (33)
New York (3046)
North Carolina (1609)
North Dakota (10)
Northern California (5516)
Ohio (354)
Oklahoma (22)
Oregon (55)
Pennsylvania (2309)
Puerto Rico (22)
Rhode Island (50)
South America (1661)
South Carolina (65)
South Dakota (1)
Southern California (4449)
Tennessee (177)
Texas (1820)
United States (41613)
Utah (346)
Vermont (1)
Virginia (290)
Washington D.C. (88)
Washington State (971)
West Virginia (4)
Wisconsin (127)
Wyoming (2)
There are 870,202 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Skye Reports Positive CBeyond Phase 2a Extension Interim Study Results for Nimacimab in Combination With Semaglutide
February 2, 2026
·
9 min read
Press Releases
Bioxytran and University of Minnesota Launch Sponsored Research Collaboration to Advance Novel Carbohydrate-Based Therapeutics
February 2, 2026
·
4 min read
Press Releases
Sagimet Announces Positive 52-Week Data from License Partner Ascletis’ Open-Label Phase 3 Clinical Trial Evaluating the Long-Term Safety of ASC40 (Denifanstat) Tablets in Patients with Moderate to Severe Acne
February 2, 2026
·
8 min read
Press Releases
EYLEA HD® (aflibercept) Injection 8 mg Presentations at Angiogenesis 2026 Underscore Strength of its Clinical Profile for the Treatment of Serious Retinal Diseases
February 2, 2026
·
14 min read
Press Releases
Aquestive Therapeutics Announces FDA Issuance of Complete Response Letter for Anaphylm™
February 2, 2026
·
15 min read
Complete response letters
FDA Warned Corcept of ‘Significant Review Issues’ For Rejected Drug in Early Meetings
Corcept’s relacorilant was rejected for hypercortisolism late last year—a decision which CEO Joseph Belanoff expressed surprise with at the time.
February 2, 2026
·
1 min read
·
Tristan Manalac
Press Releases
Harrow Reaffirms 2025 Full-Year Revenue Guidance of $270–$280 Million, Marking Another Year of Strong Growth
February 2, 2026
·
9 min read
Press Releases
Iridex Announces Plans to Relocate Headquarters
February 2, 2026
·
3 min read
Press Releases
Eton Pharmaceuticals Announces Licensing of Rare Disease Product Candidate
February 2, 2026
·
3 min read
Autoimmune disease
Amgen Ends Autoimmune Alliance With Kyowa Kirin Amid Safety, Efficacy Questions
A Phase III readout in September 2024 for rocatinlimab, on which Amgen and Kyowa Kirin were collaborating in atopic dermatitis, appeared underwhelming to analysts, with Jefferies noting that the data “came in at the lower end of efficacy and expectations.”
February 2, 2026
·
2 min read
·
Tristan Manalac
1 of 87,021
Next
